71/100 B+ · Elevated risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

DYAX CORP

Active operating 📍 burlington, ma 8731

operating · RC 0000907562

B+

Overview

DYAX CORP is a operating registered in BURLINGTON, MA, United States. The company operates in the 8731 sector. With reported revenue of 81.7M USD in 2014. Its TraceComp score of 71 (B+) indicates moderate risk with some areas to watch.

Company Information

Registration Number
0000907562
Legal Form
operating
Address
burlington, ma

Financial Profile

Latest filed accounts: FY 2014 · most recent available in public filings

Revenue (2014) 81,723,000 USD
Net Income -11,878,000 USD
Total Assets 217,133,000 USD
Altman Z 1.02 distress

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Patent Portfolio

Active patent holder. 176 patents · 106 active · 176 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Net loss reported in FY 2014
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Data Sources & Freshness

Data sourced from: bulk register.